All these markers are essential to distinguish MZL from other types of lymphomas, such as CLL/SLL (CD5+ and CD23+), mantle cell lymphoma (CyclinD1+, CD5+, CD23−), and follicular lymphoma (CD10+ and Bcl6+). This evidence concerns the gene BCL6 and B-cell chronic lymphocytic leukemia.